Cargando…

Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease. Multiple research has revealed that the extracellular matrix (ECM) may be associated with the development and prognosis of IPF, however, the underlying mechanisms remain incompletely understood. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Hong, Yan, Jisong, Zhou, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585847/
https://www.ncbi.nlm.nih.gov/pubmed/37858084
http://dx.doi.org/10.1186/s12890-023-02699-8
_version_ 1785123033565888512
author Luo, Hong
Yan, Jisong
Zhou, Xia
author_facet Luo, Hong
Yan, Jisong
Zhou, Xia
author_sort Luo, Hong
collection PubMed
description BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease. Multiple research has revealed that the extracellular matrix (ECM) may be associated with the development and prognosis of IPF, however, the underlying mechanisms remain incompletely understood. METHODS: We included GSE70866 dataset from the GEO database and established an ECM-related prognostic model utilizing LASSO, Random forest and Support vector machines algorithms. To compare immune cell infiltration levels between the high and low risk groups, we employed the ssGSEA algorithm. Enrichment analysis was conducted to explore pathway differences between the high-risk and low-risk groups. Finally, the model genes were validated using an external validation set consisting of IPF cases, as well as single-cell data analysis. RESULTS: Based on machine learning algorithms, we constructed an ECM-related risk model. IPF patients in the high-risk group had a worse overall survival rate than those in the low-risk group. The model’s AUC predictive values were 0.786, 0.767, and 0.768 for the 1-, 2-, and 3-year survival rates, respectively. The validation cohort validated these findings, demonstrating our model’s effective prognostication. Chemokine-related pathways were enriched through enrichment analysis. Moreover, immune cell infiltration varied significantly between the two groups. Finally, the validation results indicate that the expression levels of all the model genes exhibited significant differential expression. CONCLUSIONS: Based on CST6, PPBP, CSPG4, SEMA3B, LAMB2, SERPINB4 and CTF1, our study developed and validated an ECM-related risk model that accurately predicts the outcome of IPF patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-023-02699-8.
format Online
Article
Text
id pubmed-10585847
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105858472023-10-20 Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning Luo, Hong Yan, Jisong Zhou, Xia BMC Pulm Med Research BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease. Multiple research has revealed that the extracellular matrix (ECM) may be associated with the development and prognosis of IPF, however, the underlying mechanisms remain incompletely understood. METHODS: We included GSE70866 dataset from the GEO database and established an ECM-related prognostic model utilizing LASSO, Random forest and Support vector machines algorithms. To compare immune cell infiltration levels between the high and low risk groups, we employed the ssGSEA algorithm. Enrichment analysis was conducted to explore pathway differences between the high-risk and low-risk groups. Finally, the model genes were validated using an external validation set consisting of IPF cases, as well as single-cell data analysis. RESULTS: Based on machine learning algorithms, we constructed an ECM-related risk model. IPF patients in the high-risk group had a worse overall survival rate than those in the low-risk group. The model’s AUC predictive values were 0.786, 0.767, and 0.768 for the 1-, 2-, and 3-year survival rates, respectively. The validation cohort validated these findings, demonstrating our model’s effective prognostication. Chemokine-related pathways were enriched through enrichment analysis. Moreover, immune cell infiltration varied significantly between the two groups. Finally, the validation results indicate that the expression levels of all the model genes exhibited significant differential expression. CONCLUSIONS: Based on CST6, PPBP, CSPG4, SEMA3B, LAMB2, SERPINB4 and CTF1, our study developed and validated an ECM-related risk model that accurately predicts the outcome of IPF patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-023-02699-8. BioMed Central 2023-10-19 /pmc/articles/PMC10585847/ /pubmed/37858084 http://dx.doi.org/10.1186/s12890-023-02699-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Luo, Hong
Yan, Jisong
Zhou, Xia
Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning
title Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning
title_full Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning
title_fullStr Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning
title_full_unstemmed Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning
title_short Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning
title_sort constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585847/
https://www.ncbi.nlm.nih.gov/pubmed/37858084
http://dx.doi.org/10.1186/s12890-023-02699-8
work_keys_str_mv AT luohong constructinganextracellularmatrixrelatedprognosticmodelforidiopathicpulmonaryfibrosisbasedonmachinelearning
AT yanjisong constructinganextracellularmatrixrelatedprognosticmodelforidiopathicpulmonaryfibrosisbasedonmachinelearning
AT zhouxia constructinganextracellularmatrixrelatedprognosticmodelforidiopathicpulmonaryfibrosisbasedonmachinelearning